Technical Analysis for SYRS - Syros Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 12.77 3.65% 0.45
SYRS closed up 3.65 percent on Thursday, September 20, 2018, on 73 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical SYRS trend table...

Date Alert Name Type % Chg
Sep 20 New Uptrend Bullish 0.00%
Sep 20 180 Bullish Setup Bullish Swing Setup 0.00%
Sep 20 Inside Day Range Contraction 0.00%
Sep 19 Bearish Engulfing Bearish 3.65%
Sep 19 Golden Cross Bullish 3.65%
Sep 19 Slingshot Bullish Bullish Swing Setup 3.65%
Sep 19 Upper Bollinger Band Touch Strength 3.65%
Sep 18 Stochastic Reached Overbought Strength -0.23%
Sep 18 Overbought Stochastic Strength -0.23%
Sep 18 Up 3 Days in a Row Strength -0.23%

Older signals for SYRS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing medicines that control genes to transform the lives of patients with cancer, immune-mediated diseases, and other diseases. The company's gene control platform identifies gene control targets linked to genomically defined patient populations and drugging gene control targets; identifies potential new drug targets across a range of diseases; provides lens for diagnosing and segmenting patients, including those with complex/multi-factorial diseases; and allows users to advance a wave of medicines with the potential to influence multiple drivers of disease through a single target. Its pipeline includes SY-1425, a selective RARa agonist for genomically defined subsets of patients with relapsed or refractory acute myeloid leukemia and relapsed high-risk myelodysplastic syndrome; and SY-1365, a selective CDK7 inhibitor for acute leukemia. Syros Pharmaceuticals, Inc. was formerly known as LS22, Inc. Syros Pharmaceuticals, Inc. was founded in 2011 and is based in Cambridge, Massachusetts.
Is SYRS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.62
52 Week Low 6.3
Average Volume 97,265
200-Day Moving Average 11.5033
50-Day Moving Average 11.5342
20-Day Moving Average 12.1205
10-Day Moving Average 12.268
Average True Range 0.5862
ADX 25.47
+DI 22.1605
-DI 10.7147
Chandelier Exit (Long, 3 ATRs ) 11.3214
Chandelier Exit (Short, 3 ATRs ) 12.0086
Upper Bollinger Band 12.9764
Lower Bollinger Band 11.2646
Percent B (%b) 0.88
BandWidth 14.12318
MACD Line 0.3203
MACD Signal Line 0.2655
MACD Histogram 0.0548
Fundamentals Value
Market Cap 335.34 Million
Num Shares 26.3 Million
EPS -2.11
Price-to-Earnings (P/E) Ratio -6.05
Price-to-Sales 289.82
Price-to-Book 4.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.57
Resistance 3 (R3) 13.52 13.20 13.43
Resistance 2 (R2) 13.20 13.00 13.23 13.39
Resistance 1 (R1) 12.99 12.88 13.10 13.04 13.34
Pivot Point 12.67 12.67 12.73 12.70 12.67
Support 1 (S1) 12.46 12.47 12.57 12.51 12.20
Support 2 (S2) 12.14 12.35 12.17 12.15
Support 3 (S3) 11.93 12.14 12.11
Support 4 (S4) 11.98